<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03809806</url>
  </required_header>
  <id_info>
    <org_study_id>02/2019</org_study_id>
    <nct_id>NCT03809806</nct_id>
  </id_info>
  <brief_title>Four-arm Mesh for Vaginal Stump Prolapse</brief_title>
  <official_title>Four-arm Mesh for Vaginal Stump Prolapse: Surgical Technique and Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To estimate the safety and efficacy of performing modified anterior transvaginal mesh surgery
      using polypropylene mesh for treatment of advanced urogenital prolapse after hysterectomy
      (stage III and IV vc Pelvic Organ Prolapse Quantification [POP-Q] system staging).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pelvic reconstructive procedures were primarily performed using the transvaginal four arm
      polypropylene mesh, which was inserted through: upper arms- anterior part of obturator
      foramens, lower arms-ischiorectal fossas and sacrospinal ligaments. All patients underwent
      hysterectomy in the past apart from one which underwent vaginal hysterectomy during the
      procedure. Perineoplasty was performed additionally, if indicated. Subjective and objective
      evaluations included Pelvic Organ Prolapse Quantification [POP-Q] staging, preoperative and
      1-year postoperative questionnaires were performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients with vaginal stump prolapse who had undergone hysterectomy in the past</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pelvic Organ Prolapse Quantification (POPQ) 1 year after procedure</measure>
    <time_frame>1 year</time_frame>
    <description>assessment of POPQ 1 year after mesh operation, Pelvic Organ Prolapse Quantification system (POP-Q) refers to an objective, site-specific system for describing, quantifying, and staging pelvic support in women. It provides a standardized tool for documenting, comparing, and communicating clinical findings with proven interobserver and intraobserver reliability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sexual function 1 year after procedure</measure>
    <time_frame>1 year</time_frame>
    <description>assessment of sexual function before and 1 year after the procedure with the use of The Female Sexual Function Index questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary incontinence 1 year after procedure</measure>
    <time_frame>1 year</time_frame>
    <description>assessment of urinary incontinence before and 1 year after the procedure with the use of the Urogenital Distress Inventory (UDI 6) and the Incontinence Impact Questionnaire (IIQ 7) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life 1 year after procedure</measure>
    <time_frame>1 year</time_frame>
    <description>assessment of quality of life before and 1 year after the procedure with the use of The Short Form Health Survey (SF 36)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Sexual Function Abnormal</condition>
  <arm_group>
    <arm_group_label>patients after hysterectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>modified anterior transvaginal mesh surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>4-arm polypropylene mesh surgery</intervention_name>
    <description>Pelvic reconstructive procedures were performed with the use of 4-arm mesh:upper arms through- anterior part of obturator foramens, lower arms-ischiorectal fossas and sacrospinal ligaments.</description>
    <arm_group_label>patients after hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>The Female Sexual Function Index (FSFI) questionnaire</intervention_name>
    <description>patients fulfilled questionnaire before and 1 year after procedure</description>
    <arm_group_label>patients after hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>King Health Questionnaire (KHQ)</intervention_name>
    <description>patients fulfilled questionnaire before and 1 year after procedure</description>
    <arm_group_label>patients after hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pelvic Organ Prolapse Quantification (POPQ) staging</intervention_name>
    <description>Pelvic Organ Prolapse staging before and 1 year after the procedure</description>
    <arm_group_label>patients after hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Postoperative questionnaire</intervention_name>
    <description>Postoperative questionnaire assessing quality of life fulfilled by patients 1 year after procedure</description>
    <arm_group_label>patients after hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>The Short Form Health Survey (SF 36) questionnaire</intervention_name>
    <description>patients fulfilled questionnaire before and 1 year after procedure</description>
    <arm_group_label>patients after hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pelvic Organ Prolapse Quantification (POPQ) III and IV vc after hysterectomy

        Exclusion Criteria:

          -  malignant diseases

          -  unability to understand informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomasz Rechberger, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>2nd Gynecology Department Medical University in Lublin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>2nd Gynecology Department</name>
      <address>
        <city>Lublin</city>
        <zip>20-954</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 16, 2019</study_first_submitted>
  <study_first_submitted_qc>January 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2019</study_first_posted>
  <last_update_submitted>January 17, 2019</last_update_submitted>
  <last_update_submitted_qc>January 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Paweł Miotła</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>vaginal stump prolapse</keyword>
  <keyword>sexual function</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

